Month: April 2012

April 29, 2012
Inspiration files new FIX in US

Inspiration Biopharmaceuticals has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) protein for the treatment and prevention of bleeding in haemophilia B. Based on the terms of its agreement with Ipsen, Inspiration will receive a $35 million milestone …

Read article